CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate

CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate

Submitted by admin on November 24, 2020 - 10:31am
Source: 
Biopharma Reporter
News Tags: 
CureVac
Wacker Chemie
COVID-19
vaccines
MRNA
CVnCoV
Headline: 
CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate
snippet: 

Biopharma company, CureVac, and Wacker Chemie have signed a contract for the manufacturing of CureVac’s mRNA-based COVID-19 vaccine candidate - CVnCoV.

Do Not Allow Advertisers to Use My Personal information